For those of you in the SF/Bay Area this evening:

Don't miss tonight's MIT/Stanford Venture Lab, where Jeffrey Ostrove, CEO of Ceregene; David Mack, Director of early life science investments at Alta Partners; David Summa, President and CEO of Acumen Pharmaceuticals; Thorsten Melcher, Vice President of Discovery at Saegis Pharmaceuticals; and Frank Eeckman, Managing Editor of Centient Biotech Investor share the pitfalls and opportunities that face emerging neuropharmaceutical companies in today's investment climate.

Please join me, as I moderate this panel of experts through a discussion that will help entrepreneurs, researchers, venture investors and the general public learn how they too can tap into the booming neurotechnology market.

For those of you not able to attend, please pass this on those who might be interested.

Event Details:
Date: Tuesday, April 19, 2005
Time: 6:00 PM - Reception, Arbuckle Lounge, Stanford Business School
7:00 PM - Presentation & Discussion, Bishop Auditorium, SBS
Directions: (Click here)
Registration: (click here)